{
    "2020-01-06": [
        [
            {
                "time": "",
                "original_text": "上海莱士(002252.SZ)：与深圳熹丰就股权转让合同中剩余转让款的履行事宜达成和解",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "深圳熹丰",
                        "股权转让",
                        "和解"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海莱士：郑州莱士与深圳熹丰因股权转让合同纠纷和解 资产异常",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "郑州莱士",
                        "深圳熹丰",
                        "股权转让",
                        "纠纷和解",
                        "资产异常"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "股价闪崩8%！华兰生物业绩远低预期，批签发数据早有苗头 盈利能力下降",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "股价闪崩",
                        "业绩低预期",
                        "批签发数据",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "血液中的\"黄金救命药\"何时实现工业化生产？ ——重组人血清白蛋白的研发进展",
                "features": {
                    "keywords": [
                        "血液",
                        "黄金救命药",
                        "工业化生产",
                        "重组人血清白蛋白",
                        "研发进展"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}